Please enable JavaScript to continue using this application.

Compare $OBX vs $SANA | Chartloom

Compare

$OBX vs $SANA

Obsidian Therapeutics, Inc · Sana Biotechnology Inc

OBX

Obsidian Therapeutics, Inc

SANA

Sana Biotechnology Inc

Compare $OBX vs $SANA

Comparing Obsidian Therapeutics, Inc and Sana Biotechnology Inc

OBXObsidian Therapeutics, Inc

SANASana Biotechnology Inc

OBXObsidian Therapeutics, Inc

Market cap

$803M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-61.8%

52W performance

-61.8%

FCF yield

0.0%

SANASana Biotechnology Inc

Market cap

$776M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-33.4%

52W performance

-38.4%

FCF yield

-17.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

OBX

SANA

Detailed metrics comparison

OBX

Obsidian Therapeutics, Inc

SANA

Sana Biotechnology Inc

Market Cap

OBX$803M

SANA$776M

Enterprise Value

OBX$803M

SANA$719M

Price

OBX$13.00

SANA$2.79

P/E Ratio

OBXN/A

SANAN/A

P/S Ratio

OBX0.00x

SANA0.00x

EV/Sales

OBX0.00x

SANA0.00x

EV/EBITDA

OBX0.00x

SANA0.00x

P/B Ratio

OBXN/A

SANA5.60x

P/FCF Ratio

OBXN/A

SANAN/A

EV/FCF

OBX0.00x

SANA-5.33x

PEG Ratio

OBXN/A

SANAN/A

Forward P/E (NTM)

OBXN/A

SANAN/A

Forward P/S (NTM)

OBXN/A

SANAN/A

Revenue (TTM)

OBX$0

SANA$0

Revenue Growth (YoY)

OBXN/A

SANAN/A

Forward Rev Growth

OBX0.0%

SANA427.6%

Gross Margin (TTM)

OBX0.0%

SANA0.0%

Operating Margin (TTM)

OBX0.0%

SANA0.0%

EBITDA Margin (TTM)

OBX0.0%

SANA0.0%

Net Margin (TTM)

OBX0.0%

SANA0.0%

FCF Margin (TTM)

OBXN/A

SANAN/A

Net Income (TTM)

OBXN/A

SANA$-212M

FCF (TTM)

OBX$0

SANA$-135M

EPS (TTM)

OBX$0.00

SANA-$0.72

ROE (TTM)

OBX0.0%

SANA-13449.0%

ROA (TTM)

OBX0.0%

SANA-5112.0%

ROIC (TTM)

OBX0.0%

SANA-13449.0%

Cash

OBX$0

SANA$57M

Debt

OBX$0

SANA$0

Net Cash/Debt

OBX$0

SANA$57M

Current Ratio (TTM)

OBX0.00x

SANA1.38x

Quick Ratio (TTM)

OBX0.00x

SANA1.33x

Debt/Equity (TTM)

OBX0.00x

SANA0.00x

Debt/Assets (TTM)

OBX0.0%

SANA0.0%

Interest Coverage (TTM)

OBXN/A

SANAN/A

Net Debt/EBITDA (TTM)

OBX0.00x

SANA0.00x

Beta

OBX5.86

SANA2.31

52W Performance

OBX-61.8%

SANA-38.4%

YTD Performance

OBX-61.8%

SANA-33.4%

% from 52W High

OBX-74.0%

SANA-57.4%

% from 52W Low

OBX7.7%

SANA6.9%

Asset Turnover (TTM)

OBX0.00x

SANA0.00x

FCF Yield (TTM)

OBX0.0%

SANA-17.4%

Earnings Yield (TTM)

OBX0.0%

SANA-27.3%

Dividend Yield (TTM)

OBXN/A

SANAN/A

Rule of 40

OBX0.0

SANA0.0

EV/GP/RG

OBXN/A

SANAN/A

Ticker research

View OBX research View SANA research

Metric	OBX Obsidian Therapeutics, Inc	SANA Sana Biotechnology Inc
Market & Valuation
Market Cap	$803M	$776M
Enterprise Value	$803M	$719M
Price	$13.00	$2.79
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	N/A	5.60x
P/FCF Ratio	N/A	N/A
EV/FCF	0.00x	-5.33x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	427.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	N/A	$-212M
FCF (TTM)	$0	$-135M
EPS (TTM)	$0.00	-$0.72
ROE (TTM)	0.0%	-13449.0%
ROA (TTM)	0.0%	-5112.0%
ROIC (TTM)	0.0%	-13449.0%
Financial Health
Cash	$0	$57M
Debt	$0	$0
Net Cash/Debt	$0	$57M
Current Ratio (TTM)	0.00x	1.38x
Quick Ratio (TTM)	0.00x	1.33x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	5.86	2.31
52W Performance	-61.8%	-38.4%
YTD Performance	-61.8%	-33.4%
% from 52W High	-74.0%	-57.4%
% from 52W Low	7.7%	6.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	0.0%	-17.4%
Earnings Yield (TTM)	0.0%	-27.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View OBX research	View SANA research

Valuation

P/S Ratio

OBX

0.00x

SANA

0.00x

EV/FCF

SANA

-5.33x

OBX

0.00x

Growth & revenue

Forward Revenue Growth

SANA

427.6%

OBX

0.0%

Profitability & performance

Gross Margin

OBX

0.0%

SANA

0.0%

ROE

OBX

0.0%

SANA

-13449.0%

FCF Yield %

OBX

0.0%

SANA

-17.4%

52-Week Performance

SANA

-38.4%

OBX

-61.8%

Detailed metrics comparison

OBX

Obsidian Therapeutics, Inc

SANA

Sana Biotechnology Inc

Market Cap

OBX$803M

SANA$776M

Enterprise Value

OBX$803M

SANA$719M

Price

OBX$13.00

SANA$2.79

P/E Ratio

OBXN/A

SANAN/A

P/S Ratio

OBX0.00x

SANA0.00x

EV/Sales

OBX0.00x

SANA0.00x

EV/EBITDA

OBX0.00x

SANA0.00x

P/B Ratio

OBXN/A

SANA5.60x

P/FCF Ratio

OBXN/A

SANAN/A

EV/FCF

OBX0.00x

SANA-5.33x

PEG Ratio

OBXN/A

SANAN/A

Forward P/E (NTM)

OBXN/A

SANAN/A

Forward P/S (NTM)

OBXN/A

SANAN/A

Revenue (TTM)

OBX$0

SANA$0

Revenue Growth (YoY)

OBXN/A

SANAN/A

Forward Rev Growth

OBX0.0%

SANA427.6%

Gross Margin (TTM)

OBX0.0%

SANA0.0%

Operating Margin (TTM)

OBX0.0%

SANA0.0%

EBITDA Margin (TTM)

OBX0.0%

SANA0.0%

Net Margin (TTM)

OBX0.0%

SANA0.0%

FCF Margin (TTM)

OBXN/A

SANAN/A

Net Income (TTM)

OBXN/A

SANA$-212M

FCF (TTM)

OBX$0

SANA$-135M

EPS (TTM)

OBX$0.00

SANA-$0.72

ROE (TTM)

OBX0.0%

SANA-13449.0%

ROA (TTM)

OBX0.0%

SANA-5112.0%

ROIC (TTM)

OBX0.0%

SANA-13449.0%

Cash

OBX$0

SANA$57M

Debt

OBX$0

SANA$0

Net Cash/Debt

OBX$0

SANA$57M

Current Ratio (TTM)

OBX0.00x

SANA1.38x

Quick Ratio (TTM)

OBX0.00x

SANA1.33x

Debt/Equity (TTM)

OBX0.00x

SANA0.00x

Debt/Assets (TTM)

OBX0.0%

SANA0.0%

Interest Coverage (TTM)

OBXN/A

SANAN/A

Net Debt/EBITDA (TTM)

OBX0.00x

SANA0.00x

Beta

OBX5.86

SANA2.31

52W Performance

OBX-61.8%

SANA-38.4%

YTD Performance

OBX-61.8%

SANA-33.4%

% from 52W High

OBX-74.0%

SANA-57.4%

% from 52W Low

OBX7.7%

SANA6.9%

Asset Turnover (TTM)

OBX0.00x

SANA0.00x

FCF Yield (TTM)

OBX0.0%

SANA-17.4%

Earnings Yield (TTM)

OBX0.0%

SANA-27.3%

Dividend Yield (TTM)

OBXN/A

SANAN/A

Rule of 40

OBX0.0

SANA0.0

EV/GP/RG

OBXN/A

SANAN/A

Ticker research

View OBX research View SANA research

Metric	OBX Obsidian Therapeutics, Inc	SANA Sana Biotechnology Inc
Market & Valuation
Market Cap	$803M	$776M
Enterprise Value	$803M	$719M
Price	$13.00	$2.79
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	N/A	5.60x
P/FCF Ratio	N/A	N/A
EV/FCF	0.00x	-5.33x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	427.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	N/A	$-212M
FCF (TTM)	$0	$-135M
EPS (TTM)	$0.00	-$0.72
ROE (TTM)	0.0%	-13449.0%
ROA (TTM)	0.0%	-5112.0%
ROIC (TTM)	0.0%	-13449.0%
Financial Health
Cash	$0	$57M
Debt	$0	$0
Net Cash/Debt	$0	$57M
Current Ratio (TTM)	0.00x	1.38x
Quick Ratio (TTM)	0.00x	1.33x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	5.86	2.31
52W Performance	-61.8%	-38.4%
YTD Performance	-61.8%	-33.4%
% from 52W High	-74.0%	-57.4%
% from 52W Low	7.7%	6.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	0.0%	-17.4%
Earnings Yield (TTM)	0.0%	-27.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View OBX research	View SANA research